Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Sanofi

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
61/100
High Influence
$11.6M
Total Lobby Spend
4
Policy Issues
8
Lobbyists
4
Revolving Door

Sanofi reported $11.6 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

White House Office
U.S. House of Representatives
Dept of the Treasury
Dept of Transportation
Small Business Administration

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecSummit Strategies Government Affairs
HCRMEDPHA+1
3$637K
2024 Jul-SepMehlman Consulting
GOVMEDPHA+1
2$664K
2024 Apr-JunFierce Government Relations
GOVHCRPHA+1
3$485K
2024 Jan-MarK&L Gates
PHAMEDGOV+1
4$636K
2023 Oct-DecFierce Government Relations
GOVPHAMED+1
1$564K
2023 Jul-SepK&L Gates
GOVPHA
2$617K
2023 Apr-JunFierce Government Relations
HCRGOV
4$623K
2023 Jan-MarSummit Strategies Government Affairs
GOVMEDPHA+1
4$565K

Sanofi Lobbying FAQ

Sanofi has spent $11.6M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Sanofi lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Sanofi has an Influence Score of 61/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Sanofi employs 8 registered lobbyists, of whom 4 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Sanofi has contacted 5 government entities as part of their lobbying activities, including White House Office, U.S. House of Representatives, Dept of the Treasury.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.